Presentation TAVR in Oncology Patients With Severe AS January 10, 2019 REGISTER for free or LOG IN to view this content Clinical Cardiology Policy & Practice Cath Lab Structural Heart Aortic Valve Factoid Interventional cardiology malignancy Pacemaker TAVR Up Next Presentation Minimizing Permanent Pacemaker (PPM) After a Repositionable Self-Expanding TAVR Device August 29, 2019 More slides + Presentation ESC 2019 PURE Study: New Insights Into Anthropometrics and Cardiovascular Outcomes in 142,000 Adults From 21 Countries Followed For 9 Years Presenter: Darryl P. Leong September 02, 2019 Presentation ESC 2019 Temporal Trends in Incidence and Outcome of Acute Coronary Syndrome Presenter: Johannes Neumann September 01, 2019 We Recommend
Presentation Minimizing Permanent Pacemaker (PPM) After a Repositionable Self-Expanding TAVR Device August 29, 2019
Presentation ESC 2019 PURE Study: New Insights Into Anthropometrics and Cardiovascular Outcomes in 142,000 Adults From 21 Countries Followed For 9 Years Presenter: Darryl P. Leong September 02, 2019
Presentation ESC 2019 Temporal Trends in Incidence and Outcome of Acute Coronary Syndrome Presenter: Johannes Neumann September 01, 2019